442 related articles for article (PubMed ID: 24588932)
1. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
3. Markers for visceral hypersensitivity in patients with irritable bowel syndrome.
Ludidi S; Mujagic Z; Jonkers D; Keszthelyi D; Hesselink M; Kruimel J; Conchillo J; Masclee A
Neurogastroenterol Motil; 2014 Aug; 26(8):1104-11. PubMed ID: 24920528
[TBL] [Abstract][Full Text] [Related]
4. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
[TBL] [Abstract][Full Text] [Related]
5. Does meal ingestion enhance sensitivity of visceroperception assessment in irritable bowel syndrome?
Ludidi S; Conchillo JM; Keszthelyi D; Koning CJ; Vanhoutvin SA; Lindsey PJ; Leufkens AM; Kruimel JW; Jonkers DM; Masclee AA
Neurogastroenterol Motil; 2012 Jan; 24(1):47-53, e3. PubMed ID: 22050206
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
7. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
8. Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.
Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Dekker J; Buurman WA; Masclee AA
Neurogastroenterol Motil; 2015 Aug; 27(8):1127-37. PubMed ID: 26031193
[TBL] [Abstract][Full Text] [Related]
9. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
12. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff.
Ludidi S; Conchillo JM; Keszthelyi D; Van Avesaat M; Kruimel JW; Jonkers DM; Masclee AA
Neurogastroenterol Motil; 2012 Aug; 24(8):729-33, e345-6. PubMed ID: 22591192
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
[TBL] [Abstract][Full Text] [Related]
14. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
15. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
16. Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity.
Lowén MB; Mayer E; Tillisch K; Labus J; Naliboff B; Lundberg P; Thorell LH; Ström M; Engström M; Walter S
Neurogastroenterol Motil; 2015 May; 27(5):646-55. PubMed ID: 25777251
[TBL] [Abstract][Full Text] [Related]
17. Possible role of nitric oxide in visceral hypersensitivity in patients with irritable bowel syndrome.
Kuiken SD; Klooker TK; Tytgat GN; Lei A; Boeckxstaens GE
Neurogastroenterol Motil; 2006 Feb; 18(2):115-22. PubMed ID: 16420289
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating.
Jafari E; Vahedi H; Merat S; Momtahen S; Riahi A
Arch Iran Med; 2014 Jul; 17(7):466-70. PubMed ID: 24979556
[TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
Sisson G; Ayis S; Sherwood RA; Bjarnason I
Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
